Lilly Asia Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 6
Professionals
  • Investments
  • 113
  • Portfolio
  • 56
  • Exits
  • 24
Exits

Lilly Asia Ventures General Information

Description

Lilly Asia Ventures is a venture capital firm. The firm makes venture capital investments in the life sciences and healthcare sectors in Asia, with a focus on China. It was founded in 2008 and is based in Shanghai, China.

Contact Information

Year Founded
2008
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • Room 2909-14, No.168 Hubin Road
  • Huangpu District
  • Shanghai, 200021
  • China
+86 00000000000

Lilly Asia Ventures Investments (113)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
New Horizon Health 10-Jul-2020 Later Stage VC 0000 Laboratory Services (Healthcare) Generating Revenue
000000 00000000000 23-Jun-2020 00000 00000 000.00 Drug Discovery Startup
000000 0000000 05-May-2020 00000 00000 00000 Therapeutic Devices Generating Revenue/Not Profitable
000000 0000000 31-Mar-2020 00000 00000 00000 Biotechnology Generating Revenue/Not Profitable
0000000 16-Mar-2020 00000 00000 00000 Pharmaceuticals Generating Revenue
0000000 0000000000 21-Feb-2020 00000 00000 0000 Drug Discovery Generating Revenue
0000000 0000000000 11-Feb-2020 00000 00000 000.00 Drug Discovery Generating Revenue
0000000 0000000000 01-Feb-2020 00000 00000 0000 Pharmaceuticals Generating Revenue
Transcenta Holding 08-Jan-2020 Early Stage VC 00000 Drug Discovery Generating Revenue
Elpiscience 28-Dec-2019 Early Stage VC 00000 Pharmaceuticals Generating Revenue 000000 00 00.0
You’re viewing 10 of 113 investments. Get the full list »
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lilly Asia Ventures Exits (23)

Company Name Exit Date Exit Type Exit Size
Burning Rock 12-Jun-2020 IPO 00000
000000 0000000 05-Jun-2020 000 00000
000000 0000000 15-May-2020 000 00000
0000000 000 28-Feb-2020 000 00000
000000 21-Nov-2019 000000000000000000 00000
0000000000 000-000 08-Nov-2019 000 000.00
0000000000 12-Aug-2019 000 00000
0000 0000000000000 02-Jul-2019 000000000000000000 0000
NextCure 09-May-2019 IPO 0000
Turning Point Therapeutics 17-Apr-2019 IPO 00000
You’re viewing 10 of 23 exits. Get the full list »

Lilly Asia Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Lilly Asia Ventures‘s full profile, request access.

Request a free trial

Lilly Asia Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Lilly Asia Ventures Team (9)

Name Title Deals Funds Boards Office
Yi Shi Ph.D Founder & Managing Partner 0 0 0 Shanghai, China
Fei Chen Ph.D Managing Partner 0 0 Shanghai, China
Hongbo Lu Ph.D Partner 0 0 0 Shanghai, China
Jimmy Zhang Partner 0 Shanghai, China
Judith Li Partner 00 0 0 Shanghai, China
You’re viewing 5 of 9 team members. Get the full list »

Lilly Asia Ventures Co-Investors (205)

Name With Exits Lead Partner Series Industry
OrbiMed 14 0 00 Series chart Industry bar
Qiming Venture Partners 0 0 0 Series chart Industry bar
Vivo Capital 0 0 Series chart Industry bar
Hillhouse Capital Group 0 0 0 Series chart Industry bar
ARCH Venture Partners 0 0 0 Series chart Industry bar
You’re viewing 5 of 205 co-investors. Get the full list »